Erbitux Market (Types - 100 mg/50 ml Injection, and 200 mg/100 ml Injection; Applications - Head and Neck Cancer, and Metastatic Colorectal Cancer; End User - Hospital Pharmacy, Retail Pharmacies, and Others): Global Industry Analysis, Trends, Size, Share and Forecasts to 2027

A recent report published by Infinium Global Research on the erbitux market provides in-depth analysis of segments and sub-segments in the global as well as regional erbitux market. The study also highlights the impact of drivers, restraints, and macro indicators on the global and regional erbitux market over the short term as well as long term. The report is a comprehensive presentation of trends, forecasts and dollar values of the global Erbitux market. According to the report, the global erbitux market is projected to grow at a CAGR of 15% around the forecast period of 2021-2027, growing from over USD 1 billion in 2021 to around USD 3 billion in 2027.

Market Insight

Erbitux is a solution for infusion that contains the active substance cetuximab. Erbitux is basically been used to treat metastatic cancer of the colon or rectum. Erbitux is used in those patients whose tumor cells have a protein on their surfaces called epidermal growth factor receptor (EGFR) and they also contain wild-type versions of a family of genes called RAS. Erbitux is also been used to treat squamous-cell cancers of the head and neck. The most common side effects with Erbitux observed in a patient are rash, hypomagnesemia, mild or moderate reactions linked to the infusion, and raised levels of some liver enzymes, which is seen in more than 1 patient in 10. Skin reactions are been observed in more than 80% of patients

The growing demand for the treatment of metastatic colorectal cancer and head and neck cancer will drive market growth for Erbitux Market. The prevalence of cancer and the increasing number of patients being diagnosed with cancer is one of the reasons which will propel the market. The side effects of the drug-like such as severe allergic reactions are expected to hamper its market growth. Another serious side effect of Erbitux is a heart attack. Some people receive radiation therapy or cetuximab with platinum-based chemotherapy and fluorouracil experiencing heart attacks or death. The development of biosimilars in the coming years will offer new opportunities in different parts of the world.

Among the regions, North America accounted for the largest share in the global Erbitux Market. The increasing number of colorectal cancer patients and the presence of key market players in this region are expected to drive market growth in this region. However, the Asia Pacific region is anticipated to grow at the highest rate in the global Erbitux Market over the forecast period. There are more than 880,000 estimated new cases of head and neck cancers worldwide, with approximately 293,000 occurring in the Asia–Pacific region alone driving the growth of the Erbitux Market in this region due to the increasing number of patients

Segment Covered

The report on the global erbitux market covers segments such as types, applications, and end user. On the basis of types, the sub-markets include 100 mg/50 ml injection, and 200 mg/100 ml injection. On the basis of applications, the sub-markets include head and neck cancer, and metastatic colorectal cancer. On the basis of end user, the sub-markets include hospital pharmacy, retail pharmacies, and others.

Companies Profiled:

The report provides profiles of the companies in the market such as Merck, Bristol-Myers Squibb, Eli Lilly, Manus Aktteva Biopharma LLP, Hubei xinkang pharmaceutical chemical co.,ltd, Array BioPharma Inc, Wuhan Sunrise Technology Development Company Limited, Chembest Research Laboratories Limited, NKMax, and Pierre Fabre.

Report Highlights:

The report provides deep insights into the demand forecasts, market trends, and micro and macro indicators. In addition, this report provides insights into the factors that are driving and restraining the growth in this market. Moreover, The IGR-Growth Matrix analysis given in the report brings an insight into the investment areas that existing or new market players can consider. The report provides insights into the market using analytical tools such as Porter's five forces analysis and DRO analysis of erbitux market. Moreover, the study highlights current market trends and provides forecast from 2021-2027. We also have highlighted future trends in the market that will affect the demand during the forecast period. Moreover, the competitive analysis given in each regional market brings an insight into the market share of the leading players.